All Articles

Ontario's new FAST program speeds access to cancer drugs like Scemblix, challenging Canada's slow reimbursement system. Is this a new national blueprint?

A Hong Kong award for Youxin Technology offers a deeper look into the firm's strategic acquisition, its role in the GBA, and what it means for investors.

The space firm secures vital cash through a complex warrant deal, but at what cost to shareholders? All eyes are now on a critical investor vote.

Promising data for NuCana's NUC-7738 offers hope for tough-to-treat melanoma, but the biotech's financial health presents a critical hurdle.

With department stores gone, Primaris REIT is betting on a new model: mixed-use hubs with high-value tenants. Is this the future of Canadian retail?

Beyond the hype, additive manufacturing is now a force in the skies. Discover how Stratasys and Airbus are using it to build lighter, greener, faster jets.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

A new partnership aims to commercialize Arbli™, the first liquid losartan, leveraging a digital platform to solve patient adherence and capture market share.

Behind EVs, AI, and medical breakthroughs lies a hidden process. Discover how ion implantation shapes the chips that power our future and our trust in it.

Beyond a local award, Hyve Managed Hosting's recognition in Austin reveals a powerful strategy where customer-centric service fuels global expansion.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

NiCE's local data center launch in South Africa is more than a new product; it's a strategic play on compliance and advanced AI to capture the continent.

Impressive new trial data for MDNA11 could disrupt the multi-billion dollar immunotherapy market, offering real hope where standard treatments now fail.

The ESA's new elite summit, iicon, replaces E3, targeting C-suites to leverage gaming tech across healthcare, finance, and media. What's at stake?

authID's award-winning tech promises fraud-proof identity without storing your biometric data. Is this the future for securing payments, workforces, and even AI?

With extensive mineralization confirmed and $6M in fresh capital, SAGA Metals' Radar Project is rapidly de-risking a major critical minerals discovery.

A German tech firm's new platform offers a real-time map of grid capacity, aiming to solve a critical hurdle in North America's energy transition.

A CFO's $30k stock purchase is more than a headline. It's part of a pattern of insider confidence at JFB, signaling a bullish outlook.

Early Phase 1 data for VTP-1000 shows promise, but can this novel immunotherapy challenge a crowded market and change life for 80 million patients?

New data shows Kazia's paxalisib dismantles metastatic drivers and reignites immunity, signaling a strategic disruption in advanced breast cancer treatment.